Early adipose tissue wasting in a novel preclinical model of human lung cancer cachexia

Deena B. Snoke,Jos L. van der Velden,Emma R. Bellafleur,Jacob S. Dearborn,Sean M. Lenahan,Skyler C. J. Heininger,Jennifer L. Ather,Hailey Sarausky,Daniel Stephenson,Julie A. Reisz,Angelo D’Alessandro,Devdoot Majumdar,Thomas P. Ahern,Kim L. Sandler,Bennett A. Landman,Yvonne M.W. Janssen-Heininger,Matthew E. Poynter,David J. Seward,Michael J. Toth
DOI: https://doi.org/10.1101/2024.09.27.615385
2024-11-26
Abstract:Cancer cachexia (CC), a syndrome of skeletal muscle and adipose tissue wasting, reduces responsiveness to therapies and increases mortality. There are no approved treatments for CC, which may relate to discordance between pre-clinical models and human CC. To address the need for clinically relevant models, we generated tamoxifen-inducible, epithelial cell specific ( ) mice. mice develop CC over a protracted time course and phenocopy tissue, cellular, mutational, transcriptomic, and metabolic characteristics of human lung CC. CC in mice is characterized by early loss of adipose tissue, a phenotype confirmed in a large cohort of patients with lung cancer. Tumor-released factors promote adipocyte lipolysis, a driver of adipose wasting in human CC, and adipose tissue wasting was inversely related to tumor burden. Thus, mice model key features of human lung CC and suggest a novel role for early adipose tissue wasting in CC.
Cancer Biology
What problem does this paper attempt to address?